📡 Surveillance / Emerging Signal
WHO and CDC are tracking disembarked passengers while investigating whether transmission occurred between people rather than from rodents. Hantavirus cardiopulmonary syndrome carries a 30-40% fatality rate, with no specific treatment beyond supportive care.
Clinical Considerations
- Andes strain is the exception: most hantaviruses are rodent-to-human only; Andes has documented person-to-person transmission requiring close contact.
- Early presentation mimics influenza (fever, myalgias) before rapid progression to pulmonary edema, respiratory failure, and cardiovascular shock.
- No FDA-approved vaccine or antiviral exists; management is entirely supportive, often requiring ICU-level respiratory support.
- Typical US exposures involve aerosolized rodent excreta in enclosed spaces — attics, basements, sheds, garages, vehicles, and campsites.
Practice Applications
- Recognize flu-like illness with rapid pulmonary deterioration as a hantavirus red flag, especially with travel or rodent exposure history.
- Ask about recent cruise travel, cleaning of rodent-infested spaces, and outdoor exposures in unexplained febrile illness.
- Counsel patients on mask, glove, and ventilation precautions when cleaning areas with rodent activity.
- Monitor CDC and state health department advisories for evolving guidance on the cruise cluster.
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS